MotDem Platform
A clinical decision support platform that displays individual-level metrics to assist clinicians with diagnosis. Based on cognitive, neuropsychiatric, and blood marker assessments.
Platform Features
Comprehensive clinical decision support through advanced analytics and visualization
Cognitive Assessments
Mini ACE-III/MOCA assessments with normative modeling to compare individual results against population norms.
- • Global Cognition
- • Memory & Attention
- • Language & Fluency
- • Visuospatial Analysis
Neuropsychiatric Profile
MotDem and DASS/NPI assessments providing insights into neuropsychiatric symptoms and behavioral patterns.
- • Symptom Assessment
- • Behavioral Analysis
- • Mood Evaluation
- • Clinical Patterns
Blood Markers
Analysis of blood biomarkers including NfL and GFAP to support diagnostic decision-making.
- • Biomarker Analysis
- • NfL & GFAP Levels
- • Comparative Metrics
- • Clinical Significance
Functional Outcomes
Individual-level predictions of functional outcomes and disease progression using advanced modeling.
- • Disease Similarity
- • Survival Analysis
- • Event-Based Modeling
- • Outcome Predictions
Advanced Analytics
Normative Modeling
Compare clinical test scores against population norms to identify deviations.
Disease Similarity
Classification models that frame participants in reference to different dementia types.
Survival Analysis
Time-to-event modeling for predicting meaningful functional outcomes.
Event-Based Modeling
Advanced algorithms to predict disease progression and intervention needs.
Clinical Purpose: The platform aims to support clinical confidence by providing comprehensive visualizations and predictions, not to provide diagnoses or predict death, but to assist with intervention planning.